MedChemComm · 2018 · 17 citations · 60 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryEnzyme InhibitionLead Compound DesignLigand-based DesignMicrotubule Assembly InhibitionMicrotubule-targeting AgentsBiological Evaluation ReportDrug Binding Sites On TubulinInhibition Of Tubulin AssemblyNatural Product Microtubule InhibitorsSynthetic Microtubule-targeting AgentsTubulin Binding InhibitionTubulin Depolymerization InhibitorsTubulin Polymerization Inhibitors
led to cell cycle arrest at the G2/M phase in a dose-dependent manner by effectively inhibiting tubulin polymerization. Furthermore, the results of the molecular docking studies indicate that this class of compounds can bind to the colchicine-binding site of tubulin.
60
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10
Sulforhodamine B colorimetric assay for cytotoxicity screening
Vanicha Vichai, Kanyawim Kirtikara · Nature Protocols · 2006 · 3.7K citations
Drug Discovery: A Historical Perspective
Jürgen Drews · Science · 2000 · 2.7K citations
Claudiu T. Supuran, Andrea Scozzafava, Angela Casini · Medicinal Research Reviews · 2002 · 1.4K citations
Medicine, Biochemistry, Pharmacology +12